The 2nd International Conference on Tattoo Safety in the Langenbeck-Virchow-Haus in Berlin brings together experts in the fields of toxicology, legislation and manufacturing. The major aim is to communicate the inevitable requirements for a comprehensive evaluation of risks associated with the injection of tattoo inks into human skin.
Due to the current corona pandemic and the resulting need for rules of conduct, the conference will also be held as an online event.
The prevalence of the tattooed population in Europe rises continuously, and so does the diversity of used inks. The expected entry into force of the European harmonised restrictions of substances used in tattoo inks and permanent make-up (PMU) spreads a new light on consumer safety. While progress is made with regard to the identification of health risks associated with tattoos, many adverse conditions such as systemic sensitisation or toxicity of degradation products remain unresolved.
- Health Risks of Tattoos: Clinical Evidence
- Epidemiology and Risk Assessment
- Regulation of Tattoo Inks: Chances and Challenges
- Analytics and Enforcement
- Stakeholder Positions
- Panel Discussion and Farewell
- Professor Wolfgang Bäumler, University Hospital Regensburg, Germany
- Professor Jorgen Serup, Bispebjerg Hospital, Copenhagen University, Denmark
- Dr Nicolas Kluger, MD, Helsinki University Hospital, Finland
- Dr Milena Förster, International Agency for Research on Cancer, Paris, France
- Dr Franz Fiala, Office of the Consumer Council operated by the Austrian Consumer Association, Vienna, Austria
- Linda Katz, MD, United States Food and Drug Administration, Silver Spring, USA
- Dorte Bjerregaard Lerche, Ministry of Environment and Food of Denmark, Copenhagen, Denmark
- Dr Urs Hauri, Kanton Basel-Stadt, Kantonales Laboratorium, Switzerland
- Dr Ines Schreiver, German Federal Institute for Risk Assessment, Berlin, Germany
- Dr Steffen Schubert, Information Network of Departments of Dermatology, Göttingen, Germany
- Dr Ingrid Neudorfer-Schwarz, Bavarian State Office for Health and Food Safety, Erlangen, Germany
- PD Dr Maja A. Hofmann, Charité, Berlin, Germany
- Ana Maria Blass Rico, European Commission, Brussels, Belgium